FFF Enterprises is Offering ZIMHI^® (naloxone HCl Injection), Manufactured by ZMI Management Inc.

Now available exclusively through FFF Enterprises.

ZIMHI (naloxone HCl Injection) is for intramuscular or subcutaneous use (5 mg/0.5mL single-dose, prefilled syringe) and is a higher-dose injectable naloxone for opioid overdose.

* To learn more about the product, please read the Prescribing Information.

Combat the opioid epidemic by being prepared with ZIMHI. When every second counts.

On May 15, 2024, the U.S. Centers for Disease Control and Prevention released the following statement: “We…lost over 100,000 people last year; meaning, there are still families and friends losing their loved ones to drug overdoses at staggering numbers.”